RHBC
AGN

R.H. Bluestein & Co’s Allergan Inc AGN Stock Holding History

R.H. Bluestein & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,035
Closed -$1.25M – 404
2014
Q1 		$1.25M Sell
10,035
-2,557
-20% -$311K 0.08% 92
2013
Q4 		$1.4M Buy
12,592
+10,050
+395% +$960K 0.09% 82
2013
Q3 		$230K Sell
2,542
-730
-22% -$65.5K 0.02% 303
2013
Q2 		$276K Buy
+3,272
New +$339K 0.02% 257

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

R.H. Bluestein & Co's AGN Position: Q2 2014 in Review

R.H. Bluestein & Co sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 10,035 shares — an estimated $1.25M sold.

R.H. Bluestein & Co first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $1.4M in Q4 2013. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • R.H. Bluestein & Co reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
  • R.H. Bluestein & Co sold 10,035 Allergan Inc shares in Q2 2014, an estimated $1.25M.
  • R.H. Bluestein & Co first reported a position in Allergan Inc in Q2 2013 and held it in 4 quarters.
  • R.H. Bluestein & Co's Allergan Inc position peaked at $1.4M in Q4 2013.
  • 770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on R.H. Bluestein & Co's 13F filing for Q2 2014, filed 13 Aug 2014.